semaglutide cardiovascular risk Weight loss and disease outcomes of semaglutide: a one-year multicentered study 🚨 Breaking News: Real-World Data

Weight gain during perimenopause is a common concern, which is exacerbated by hormonal changes

Patients should be counselled that improvements in blood glucose control may develop gradually over several weeks

Acetaminophen remains the preferred option for its stomach-friendly properties, while NSAIDs like ibuprofen should be used sparingly and with food

Im sensing an inflection point

GLP-1 medicationsmore commonly known by their brand names such as Ozempic and Wegovy have the potential to reshape the eating and shopping habits of users

When we ran her body composition analysis, we discovered she'd lost almost as much muscle as fat